首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy
【24h】

The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy

机译:Hsp90α分泌的调控机制及其在恶性肿瘤中的作用

获取原文
获取原文并翻译 | 示例
       

摘要

Heat shock protein 90-α (Hsp90α) is an intracellular molecular chap-erone. However, it can also be secreted with the underlying regulatory mechanism remaining far from clear. Here we show that the secreted Hsp90α is a C-terminal truncated form and its secretion is regulated by the C-terminal EEVD motif via interacting with proteins containing tetratricopeptide repeat domains. We also demonstrate that secretion of Hsp90« is determined by the phosphorylation status at residue Thr-90, regulated by protein kinase A and protein phos-phatase 5. We further demonstrate that the secretion of Hsp90α is a prerequisite for its proinvasiveness function and blocking the secreted Hsp90α results in significant inhibition of tumor metastasis. Meanwhile, the level of plasma Hsp90α is positively correlated with tumor malignancy in clinical cancer patients. In sum, our results reveal the regulatory mechanism of Hsp90α secretion, and its function in tumor invasiveness, indicating it can be a promising diagnostic marker for tumor malignancy in clinical application.
机译:热激蛋白90-α(Hsp90α)是一种细胞内分子伴侣。但是,它还可以在基本的调节机制还很不清楚的情况下被分泌出来。在这里,我们显示了分泌的Hsp90α是C末端的截短形式,其分泌受C末端EEVD基序与包含四肽重复结构域的蛋白质相互作用的调节。我们还证明了Hsp90«的分泌取决于蛋白质激酶A和蛋白磷酸酶5调控的残基Thr-90的磷酸化状态。我们进一步证明了Hsp90α的分泌是其促侵袭功能和阻断Hsp90α的先决条件。分泌的Hsp90α可显着抑制肿瘤转移。同时,血浆Hsp90α水平与临床癌症患者的肿瘤恶性程度呈正相关。总之,我们的结果揭示了Hsp90α分泌的调节机制及其在肿瘤侵袭性中的功能,表明它可以在临床应用中成为肿瘤恶性肿瘤的有前途的诊断标志。

著录项

  • 来源
  • 作者单位

    National Engineering Laboratory for Anti-tumor Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Beijing Key Laboratory for Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Cancer Biology Laboratory, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

    National Engineering Laboratory for Anti-tumor Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Beijing Key Laboratory for Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Cancer Biology Laboratory, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

    National Engineering Laboratory for Anti-tumor Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Beijing Key Laboratory for Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Cancer Biology Laboratory, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

    National Engineering Laboratory for Anti-tumor Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Beijing Key Laboratory for Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Cancer Biology Laboratory, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

    Cancer Biology Laboratory, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

    Cancer Biology Laboratory, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

    National Engineering Laboratory for Anti-tumor Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Beijing Key Laboratory for Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Cancer Biology Laboratory, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

    National Engineering Laboratory for Anti-tumor Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

    National Engineering Laboratory for Anti-tumor Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Beijing Key Laboratory for Protein Therapeutics, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China Cancer Biology Laboratory, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    heat shock protein 90-α; extracellular; nonconventional protein secretion; MMP-2; tumor marker;

    机译:热激蛋白90-α;细胞外非常规蛋白质分泌MMP-2;肿瘤标志物;
  • 入库时间 2022-08-18 00:42:11

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号